| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 0.65/gram
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Cetilistat, ATL-962 is a new gastrointestinal lipase inhibitor. It forms a covalent bond with the active serine sites of gastric lipase and pancreatic lipase in the stomach and small intestine to inactivate the enzyme. To play a therapeutic role, inactivated enzymes cannot degrade the lipids in the food. Chemicalbook fats are mainly triglycerides that are hydrolyzed into absorbable free fatty acids and monoacylglycerols. Undigested triglycerides cannot be absorbed by the body, thereby reducing caloric intake. Weight control.
Cetilistat is a new type of pancrelipase inhibitor for obesity in diabetic and non-diabetic patients. The main purpose of new lipristal: a new type of weight loss product, and can be used for smoking cessation; indications: new type of weight loss, smoking cessation, lowering blood lipids, pharmaceutical raw materials.
| Olivetol | Alpga GPC | Phenibut | Aniracetam |
| Piracetam | Pramiracetam | Coluracetam | Fasoracetam |
| PRL-8-53 | NSI-189 | PPH | Compound 7P |
| Sunifiram | Tianeptine | 9-Methyl-9H-beta-carboline | Magnesium L-Threonate |
){kind=link}